Stay informed with the latest litigation news. Explore now

Complexes Of Sirolimus And Its Derivatives, Process For The Preparation Thereof And Pharmaceutical Compositions Containing Them - EP3104844B1

EP3104844

DRUGGABILITY HOLDCO
Application Number
EP15710913A
Filing Date
Feb 13, 2015
Status
Revoked
Apr 15, 2022
Grant Date
Feb 12, 2020
External Links
Slate, Register, Google Patents
Similar Patents facing opposition

Bibliography

The patent EP3104844B1 was granted to Druggability Holdco on Feb 12, 2020 following the initial filing on Feb 13, 2015 under the application number EP15710913A . The current legal status of the patent is Revoked.

Patent Summary

Patent Family New

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

ALKERMES PHARMA IRELANDNov 11, 2020 -

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents